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Abstract
Reactive oxygen species (ROS) generated by Nicotinamide adenine dinucleotide phosphate
oxidase (NOX) is required for liver fibrosis. This study investigates role of NOX in ROS
production and the differential contribution of NOX from bone marrow (BM) derived and non-
BM derived liver cells. Hepatic fibrosis was induced by bile duct ligation (BDL) for 21 days or by
methionine-choline deficient (MCD) diet for 10 weeks in wild-type (WT) mice and mice deficient
in p47phox (p47phox KO), a component of NOX. p47phox KO chimeric mice were generated by
the combination of liposomal clodronate injection, irradiation and BM transplantation of p47phox
KO BM into WT recipients and vice versa. Upon BDL, chimeric mice with p47phox KO BM-
derived cells, including Kupffer cells (KC), and WT endogenous liver cells showed a ~25%
reduction of fibrosis, while chimeric mice with WT BM-derived cells and p47phox KO
endogenous liver cells, including hepatic stellate cells (HSC), showed a ~60% reduction of
fibrosis. In addition, p47phox KO compared to WT mice treated with an MCD-diet showed no
significant changes in steatosis and hepatocellular injury, but a ~50% reduction in fibrosis.
Cultured WT and p47phox KO HEP treated with free fatty acids (FFA) had a similar increase in
lipid accumulation. FFA promoted a 1.5 fold increase in ROS production both in p47phox KO and
in WT hepatocytes (HEP).
Conclusion—NOX in both BM derived and non-BM derived cells contributes to liver fibrosis.
NOX does not play a role in experimental steatosis and the generation of ROS in HEP, but exerts a
key role in fibrosis.
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INTRODUCTION
Liver fibrosis is the consequence of chronic liver injury and represents an important cause of
mortality worldwide (1,2). Liver fibrosis results from inflammation associated with the
production of chemokines and cytokines that stimulate and act on different cells in the liver,
including hepatic stellate cells (HSC), Kupffer cells (KC), hepatocytes (HEP), and
endothelial cells (3,4). The endpoint of advanced liver fibrosis is cirrhosis, in which the
fibrous scar and regenerating nodules lead to hepatocellular dysfunction, portal
hypertension, and hepatocellular carcinoma (5,6). An inflammation-fibrosis-cancer axis has
therefore been proposed (7). Oxidative stress plays an important role in inflammation,
fibrosis, and cancer (8–10). Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase
(NOX), a key source of reactive oxygen species (ROS) in the liver (11), may therefore
represent an important new therapeutic target (12). NOX is a multiprotein complex that
catalyzes ROS formation in response to many stimuli (9,13). Macrophages, including KC,
express the phagocytic form of NOX that plays a crucial role in antimicrobial defence (8,14–
16). The non-phagocytic form of NOX is expressed in other cell types, such as vascular
smooth muscle cells and cardiac myofibroblasts, and is required for the proper activation of
many intracellular signalling pathways, including mitogen-activated protein kinase (MAPK)
and PI3K (11,17,18). We have previously shown that NOX is required for hepatic fibrosis in
vivo (9). KC express the majority of NOX in the liver and play an important role in HSC
activation (19). However, NOX is also expressed by HSC and is able to mediate hepatic
stellate cell activation in response to fibrogenic agonists such as platelet-derived growth
factor (PDGF), angiotensin II (Ang II) and leptin (9,18,20). Furthermore, HEP contain NOX
(21), providing a potentially additional sources of ROS in inflammation and fibrosis.
However, the relative contribution of NOX in KC, HEP and HSC to hepatic inflammation
and fibrosis remains unknown. This study demonstrates that NOX-mediated formation of
ROS in non-BM derived liver cells play a key role in liver fibrosis.
MATERIAL AND METHODS
Chemicals
2′7′-Dichlorofluorescein diacetate (CM-H2 DCFDA) was purchased from Molecular Probe
Inc. (Eugene, OR). Palmitic acid was purchased from Sigma Aldrich (St. Louis, MO).
Animal and treatment
p47phox-deficient mice on a C57BL/6 background, which lack a critical cytosolic
component required for assembly of an active NADPH oxidase complex, and p47phox-
sufficient wild-type (WT) C57BL/6 control mice were purchased from Taconic Corp.
(Hudson, NY) (22). Six to eight week-old male mice were used for liver injury experiments
and for diet treatment. Liver fibrosis was induced either by bile duct ligation (BDL) or by
intra-peritoneal injection of the hepatotoxin carbon tetrachloride (CCl4). Mice were housed
in a pathogen-free barrier facility accredited by the Association for the Accreditation and
Assessment of Laboratory Animal Care.
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Diet treatment
Mice were fed ad libitum a high-fat, methionine and choline-deficient (MCD) diet (ICN
Biomedicals, Sydney, Australia) for up to 10 weeks (23). Controls were pair-fed the same
diet supplemented with choline chloride (2 g/kg) and DL-methionine (3 g/kg) (MCS diet).
Cell culture
Mouse HEP were isolated from WT and P47phox-deficient mice as described previously
(9,11). HEP were subsequently plated on dishes coated with type I collagen and cultured in
Waymouth’s medium (GIBCO BRL; Life Technologies) containing 10% fetal bovine
serum, 0.1 mmol/l insulin, and 0.1 mmol/l dexamethasone. After 2 hours, the cultures were
washed with phosphate buffered saline and changed to RPMI medium (GIBCO BRL). HEP
were incubated with agonists for an additional 12 hours (24). HEP, KC, endothelial cells,
fibrocytes and HSC were isolated from control and BDL mice, as previously described
(9,25,26).
Histochemical studies
Paraffin-embedded sections were stained with H&E and Sirius red. For
immunohistochemical analysis, sections were deparaffinized, rehydrated, and stained using
the DAKO EnVision system protocol (DAKO, Carpinteria, CA). Sections were incubated
with anti alpha-Smooth Muscle Actin (α-SMA) (1:1,000; DAKO) or 4-hydroxynonenal (4-
HNE) for 30 minutes at room temperature. As negative controls, all specimens were
incubated with an isotype-matched control antibody. The area of positive staining was
measured using a computer-based morphometric analysis system. For immunofluorescence
analysis, frozen sections were incubated with antibodies for 4-HNE, α-SMA (DAKO), F4/80
(eBioscience) or pan-cytokeratin (Biolegend) overnight.
Quantification of hepatic collagen content
Collagen content was assessed by both morphometric analysis of Sirius red staining of liver
sections and by hydroxyproline concentration. The area of positive Sirius red staining was
measured using a computerized analysis method. Hydroxyproline content was quantified
colorimetrically from 0.1 g liver samples.
Measurement of intracellular ROS
Cells cultured in 24-well plates were loaded with the redox-sensitive dye DCFDA (10 μM)
for 20 minutes at 37°C. Cells were then stimulated with an agonist. DCFDA fluorescence
was detected at excitation and emission wavelengths of 488 nm and 520 nm, respectively
(9). ROS formation was measured using a multiwell fluorescence scanner (CytoFluor 2300;
Millipore, Bedford, MA).
Western blotting
Liver extracts were obtained in a modified radioimmunoprecipitation buffer as described
previously (18). Western blotting was performed using standard protocols. An antibody
against α-SMA (Sigma-Aldrich) was used at the concentration of 1:1000. Horseradish
peroxidises-conjugated secondary antibodies were used and visualized using enhanced
chemiluminescence.
Bone marrow transplantation
Bone marrow transplantation (BMT) was performed as described previously (25). Mice
received an intravenous injection of liposomal clodronate (200 μl intravenously) before
irradiation to deplete KC (27). Tibias and femurs of donor mice were flushed to obtain bone
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marrow (BM). 1×107 BM cells were injected into the tail veins of lethally irradiated (11 Gy)
recipient mice. BDL was performed 12 weeks after BMT. To determine successful BMT in
p47phox-deficient and p47phox-sufficient mice, spleen cells were isolated from BDL
chimeric mice and analyzed by quantitative real-time polymerase chain reaction (RT-PCR)
to measure p47phox mRNA expression (data not shown).
Quantitative real-time PCR
RT-PCR was used for measuring mRNA levels of fibrogenic markers (Collagen α1(I) and
αSMA). Extraction of RNA from total liver mice was performed by a combination of
TRIzol (Invitrogen, Carlsbad, CA) and RNeasy columns (Qiagen, Valencia, CA). cDNA
was obtained using the Amersham kit for cDNA synthesis (11).
Statistical analysis
Results are expressed as mean ± SEM. The results were analyzed using the unpaired
Student’s t test or the Newman-Keuls test. A p value of less than 0.05 was considered
statistically significant.
RESULTS
p47phox-deficient mice are resistant to liver fibrosis induced by BDL or CCl4
To assess the role of the NOX in liver fibrosis, p47phox knock out (KO) mice were
subjected to two different models of hepatic damage: BDL as a model of cholestatic liver
injury and CCl4 treatment as a model of toxic liver injury. Consistent with our previous
studies (9), mice deficient for the p47phox component of NOX had reduced fibrosis after
three weeks of BDL, as evaluated by collagen deposition and α-SMA staining (Fig. 1A, B).
Furthermore, the critical role of NOX in liver fibrosis was confirmed in mice subjected to
intra-peritoneal injection of CCl4. Mice received 16 injections of CCl4 (0.5 μL/g; twice
weekly) and were sacrificed two days after the last injection. WT mice displayed a
significant increase in collagen deposition and α-SMA staining following treatment with
CCl4 compared to vehicle treated mice (Fig. 1C, D). The increase in fibrotic parameters was
significantly reduced in p47phox-deficient mice (Fig. 1C, D). In addition, mRNA levels of
collagen α1(I) and α-SMA were significantly reduced in p47phox-deficient mice compared
to p47phox-sufficient mice either after three weeks of BDL or after 16 injections of CCl4 as
evaluated by RT-PCR (Fig. 1E, F). Moreover, the protein expression of α-SMA was reduced
in p47phox-deficient mice in comparison to p47phox-sufficient mice, either after BDL or
CCl4 (Fig. 1E, F). These data demonstrate that NOX plays a crucial role in the pathogenesis
of liver fibrosis in two complimentary models of liver injury.
NOX in hepatic stellate cells plays a crucial role in cholestatic liver injury
To investigate the expression of NOX in different cell population of the liver, we performed
RT PCR for the mRNA levels of the main components of NOX activity in different cells of
the liver: fibrocytes, KC, HEP, endothelial cells and HSC. The data showed that the
p47phox component is mainly expressed in KC, among the BM-derived cells, and in HSC,
among the non-BM-derived cells (Fig. 2A). Surprisingly, HEP expressed p47phox.
Furthermore, the data showed a lower expression of this component in other cell types of the
liver (Fig. 2A). Concordantly with the p47phox mRNA expression in the different hepatic
cell types, we performed double immunofluorescence staining between 4-HNE (a lipid
peroxidation product as a general marker of ROS) and cell type markers F4/80, αSMA and
pan-cytokeratin for KC, HSC and parenchymal cells, respectively. 4-HNE was expressed in
KC and HSC in the livers of BDL mice (Fig. 2B,C). Some HEP also express ROS in BDL
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mice (Fig. 2D). We further confirmed that these cell types express ROS in the livers of
CCl4-treated mice (Sup Fig. 1).
To investigate the role of NOX from different hepatic cell types in liver fibrosis, BMT was
employed to generate chimeric mice. BM from p47phox-sufficient mice was transplanted
into p47phox-deficient mice and vice versa, obtaining mice with NOX-sufficient BM-
derived cells, including KC and NOX-deficient endogenous liver cells (non-BM derived),
including HSC, and vice versa. As controls, BM from p47phox-deficient mice was
transplanted into p47phox-deficient mice and BM from p47phox-sufficient mice was
transplanted into p47phox-sufficient mice. This strategy produced 4 different groups of
mice: 1) WT BM → p47phox KO mice, 2) WT BM → WT mice, 3) p47phox KO BM →
WT mice, 4) p47phox KO BM → p47phox KO mice. We have previously shown that this
strategy is useful in discriminating signalling pathways between HSC and KC (25). In
summary, this resulted in mice with HSC deficiency for p47phox but with normal KC
(group 1), mice with intact NOX in all cells (group 2), mice with NOX-deficient KC but WT
HSC (group 3), and mice deficient for NOX in all cells (group 4). These mice were then
subjected to BDL for 3 weeks.
As expected from our above results, mice with intact NOX (group 2) showed the most
fibrosis and mice deficient for p47phox in all cells (KO → KO, group 4) showed the least
fibrosis (Fig. 3A–C). Deficiency for p47phox in either BM derived or non-BM derived cells
resulted in attenuated liver fibrosis following 3 weeks of BDL as evaluated by collagen
deposition and hydroxyproline content compared to mice with functional p47phox in all
cells (WT BM → WT mice, group 2) (Fig. 3A–C). Furthermore, chimeric mice with NOX-
deficient endogenous liver cells, including HSC, but WT BM derived cells, including KC,
(WT BM → p47phox KO mice, group 1), showed reduced levels of collagen deposition and
hydroxyproline content in comparison to chimeric mice with NOX-sufficient endogenous
liver cells, including HSC, but NOX-deficient BM derived cells (p47phox KO BM → WT
mice, group 3) (Fig. 3A–C). Accordingly, chimeric mice with NOX-deficient endogenous
liver cells but WT BM derived cells showed a significant reduction of α-SMA expression, as
demonstrated by immunohistochemistry and western blotting (Fig. 3D, E). Moreover,
mRNA expression for α-SMA and collagen α1(I) confirmed the reduced expression of
fibrogenic markers in chimeric mice with NOX-deficient HSC (Fig. 3F). These results
suggest that NOX-mediated generation of ROS in endogenous liver cells, including HSC, is
more important than in BM derived cells, including KC, for the development of fibrosis
following cholestatic liver injury.
Chimeric mice with NOX-deficient endogenous liver cells showed reduced peroxidation
NOX generates ROS in many cell types. To investigate the levels of peroxidation in the
NOX-chimeric livers, mice subjected to BMT were analyzed for peroxidation by
immunohistochemistry for hydroxynonenal adducts. As expected, NOX-deficient mice
showed reduced peroxidation in comparison to NOX-sufficient mice. Interestingly, chimeric
mice with NOX-deficient HSC showed a reduced level of peroxidation, confirming the
importance of oxidative stress produced by NOX in HSC during the process of liver fibrosis.
(Fig. 4A).
Peroxidation was also measured in whole liver samples by thiobarbituric acid reactive
substances (TBARS) assays. Peroxidation in chimeric livers with NOX-deficient hepatic
stellate cells had a greater reduction in lipid peroxidation than the chimeric livers with
NOX-deficient KC. In fact, the level of peroxidation produced by these chimeric mice was
similar to the peroxidation in complete p47phox KO mice (Fig. 4B).
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To better differentiate the ROS activity in the different cell type in the liver, we performed
double immunofluorescence for 4-HNE and αSMA in the chimeric mice (Fig. 4C, D). The
experiment showed a co-localization of ROS production (HNE stain) and HSC in chimeric
mice with p47phox KO BM (p47phox KO BM → WT mice) subjected to BDL (Fig. 4C),
while HSC express little ROS in the chimeric mice with p47phox KO endogenous liver cells
(WT BM→ p47phox KO mice) subjected to BDL (Fig. 4D), suggesting that NOX is a major
contributor in HSC.
MCD diet induces hepatic steatosis independent of NADPH oxidase
To investigate the role NOX in a mouse model of non-alcoholic steatohepatitis (NASH)
ultimately leading to fibrosis, NOX-deficient (p47phox KO) mice and WT controls were fed
an MCD diet for 10 weeks. Although both WT and KO mice fed the MCD diet lost weight,
the liver weight-body weight fraction revealed an increase in steatosis of the liver of all
MCD-treated mice (Fig. 5A). In addition, the serum transaminases levels were significantly
higher both in WT and KO mice fed the MCD diet than the MCS diet (Fig. 5B), suggesting
an equal degree of steatosis and of hepatocellular damage both in WT and in KO mice. To
confirm these results, RT-PCR for the mRNA of inflammatory markers such as MCP-1 and
TNFα showed no significant differences in WT and KO mice fed the MCD diet (Fig. 5C).
However, there was significant difference in the mRNA expression of TIMP-1, a marker of
HSC activation (Fig. 5C).
Livers from mice fed an MCD diet showed significant deposition of triglycerides, with
macro-and micro-nodular distribution of fat as evaluated by Oil-red O staining compared to
mice fed a control diet supplemented with methionine and choline (Fig. 5D, E). The higher
deposition of fat in mice fed the MCD diet was confirmed by measuring hepatic
triglycerides content (Fig. 5F). A slight increase in fat deposition in mice receiving the MCS
control diet was observed compared to mice fed a normal chow diet (Fig. 5D, E). There was
no difference in hepatic lipid content between NOX-deficient and WT mice (Fig. 5D–F).
This suggests that NOX is dispensable for fat accumulation in a mouse model of non-
alcoholic fatty liver disease (NAFLD).
MCD diet induces similar levels of peroxidation in the livers of WT and NOX-deficient mice
Oxidative stress is a hallmark of NASH, which is recapitulated in mice fed an MCD diet.
Reductions in antioxidant defence mechanisms as well as increases in ROS production are
attributed to methionine-choline deficiency. Immunohistochemistry for 4-HNE adducts
showed similar staining in the livers of NOX-deficient (p47phox KO) and WT mice fed an
MCD diet, indicating a diet induced increase in ROS production that is independent of NOX
(Fig. 6A). Accordingly, TBARS levels were significantly increased in mice fed an MCD
diet compared to MCS diet, but no difference between WT and KO mice was observed (Fig.
6B). This result was confirmed by immunofluorescence staining in MCS and MCD fed mice
that revealed 4-HNE in the hepatocytes of both WT and KO MCD fed mice (Fig. 6C). Thus,
the generation of total hepatic ROS in this NASH model is independent of NOX.
NOX is critical for the development of MCD diet induced liver fibrosis
Even if NOX does not affect fat accumulation and generation of total hepatic ROS, it might
still affect the development of liver fibrosis following an MCD diet. Sirius red staining
indicated that feeding an MCD diet for 10 weeks results in significant fibrosis in WT mice
compared to mice fed an MCS diet. However, NOX-deficient (p47phox KO) mice fed an
MCD diet failed to develop fibrosis (Fig. 7A). Collagen α1(I) and α-SMA mRNAs were
increased in WT mice fed an MCD diet in comparison to mice fed the control MCS diet.
This increase in fibrogenic markers was significantly attenuated in NOX-deficient mice fed
an MCD diet (Fig. 7B). Collectively, these data suggest that NOX is not involved in lipid
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metabolism and hepatic fat accumulation but NOX is required for the development of
fibrosis in the metabolic model of liver disease. Indeed, HSC express ROS in WT, but not
NOX-deficient, mice fed an MCD diet (Sup Fig. 2)
FFA-induced ROS production in HEP is NOX-independent
Our data suggest that the MCD diet causes steatosis and oxidative stress independent of
NOX, but that the subsequent development of fibrosis in this model of metabolic liver injury
relies on NOX. To further evaluate the role of NOX in HEP, we isolated primary HEP from
NOX-deficient (p47phox KO) and WT mice and incubated them with palmitic acid (200
μM) for 12 hours. Oil-red O staining showed a similar extent of triglyceride accumulation in
WT and NOX-deficient HEP (Fig. 8A). Moreover, incubation with palmitic acid caused a
significant increase in ROS production as evaluated by DCFDA measurement in comparison
to untreated cells (Fig. 8B). However, increases in ROS production were similar between
WT and p47phox-deficient HEP (Fig. 8B). Thus, NOX is not required for FFA-induced
triglyceride accumulation and ROS generation in HEP.
DISCUSSION
NOX is a multi-protein complex that generates ROS in response to a wide range of stimuli
(28). In the liver, NOX is expressed in both phagocytic and non-phagocytic forms. Chronic
liver diseases are characterized by increased ROS production as well as decreased activity of
antioxidant systems, resulting in oxidative stress (29). This feature is commonly detected in
patients with alcoholic liver disease, hepatitis C virus infection, hemochromatosis, and
cholestatic liver diseases. Similar observations were made in experimental models of liver
fibrosis. Oxidative stress is not only a consequence of chronic liver injury but also
significantly contributes to excessive tissue remodelling and fibrogenesis (30). NOX has
emerged as a primary source of ROS in liver disease. KC in the liver mainly produces ROS
through the phagocytic form of NOX (16), which exerts an important role in host defence
and inflammation (31). HSC express a non-phagocytic form of NOX, which plays a critical
role in activating signalling pathways (9,32). Fibrogenic agonists such as Ang II, leptin,
PDGF, and apoptotic bodies activate NOX in cultured HSC (9,17,18,20,33). Both
pharmacological inhibition with diphenyleneiodonium (DPI) (34) and genetic studies using
p47phox-deficient mice provided evidence for a central role of NOX in the regulation of
HSC activation and liver fibrosis. Whereas there is convincing data regarding the in vitro
activation of HSC (35), the contribution of NOX in different hepatic cell types to hepatic
fibrogenesis in vivo remains mostly unknown. Since KC are the major source of phagocytic
NOX in the liver and are required for HSC activation and fibrogenesis (36), it could be
possible that phagocytic NOX is the main mediator of hepatic fibrogenesis (37), or that both
KC and HSC mediate fibrogenesis. Our study used BMT to compare the contribution of
NOX-derived ROS from BM-derived cells, including KC, and endogenous liver cells,
including HSC, to hepatic fibrosis. Our data show that NOX in both BM-derived cells and
endogenous liver cells contributes to liver fibrogenesis.
Earlier studies proposed that the NOX in Kupffer cells was critical for alcoholic liver
disease (38). However, this model produced steatosis and inflammation, but not fibrosis. In
fact, the current study demonstrated that chimeric mice with NOX-deficient HSC but WT
KC had the greatest reduction in liver fibrosis. The possibility of creating a selective
inhibition of the non-phagocytic form of NOX (39–41) without the involvement of the
phagocytic form should significantly reduce the fibrogenic pathway without affecting host
defence mechanisms related to the functionality of the phagocytic form of NOX (42).
NAFLD, the liver manifestation of the metabolic syndrome, may progress to liver fibrosis
and cirrhosis(43). Moreover, while the main source of ROS production in both viral and
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ethanol appears to result from activation of NOX (44–46), the role of NOX in NAFLD is
still unclear. In fact, the main cell types involved in ROS production during NAFLD are
perhaps HEP (47). HEP express a functional form of NOX that participates in CD95-
induced cell death (21). Our study demonstrates that the development of steatosis, lipid
peroxidation and inflammation caused by an MCD diet are independent from the p47
subunit of the NOX. This conclusion was supported by data showing the same triglyceride
accumulation and ROS in primary cultures of HEP isolated from p47phox KO and WT
mice. In fact, the majority of ROS production in MCD-induced liver injury is derived from
hepatocellular lipid deposition and subsequent peroxidation. Other sources of ROS in HEP
are the cytochrome P450s and mitochondrial respiratory chain (48,49).
However, our study revealed that NOX does play a role in the steatosis-inflammation-
fibrosis axis in NAFLD, in that NOX-deficient mice express little ROS in HSC, and develop
less fibrosis compared to WT mice on an MCD diet for 10 weeks (Fig. 7, Sup Fig. 2). Thus,
NOX was required for ROS generation in HSC and fibrosis but not steatosis or ROS
generation in HEP in this model of NAFLD. However, because the MCD diet is not as
robust in inducing liver fibrosis as BDL or CCl4, we could not perform the same chimeric
liver studies to further identify the key cell types expressing NOX in the NASH model.
Another mechanism of fibrogenesis is represented by apoptosis and then phagocytosis of
apoptotic bodies (33). Apoptotic bodies may directly or indirectly, through KC, activate
HSC and promote myofibroblastic transdifferentiation. NOX plays a critical role in the
process of phagocytosis in response to apoptotic bodies that are generated during liver
injury. Thus, the reduced fibrosis observed in p47 KO mice may be related to the inhibition
of the fibrogenic mechanism induced by apoptotic bodies.
In conclusion, our study points to a crucial role of non-phagocytic NOX in liver fibrosis but
not steatosis in experimental liver fibrosis including NAFLD. Thus, not all ROS is the same,
so that ROS generated by NOX in HSCs in fibrogenic, while ROS generated in steatotic
hepatocytes is NOX-independent. Specific inhibition of non-phagocytic NOX components
may inhibit fibrosis without interfering with the immune host defences, and thus represent a
promising pharmacological target.
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4-HNE 4-hydroxynonenal
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MCS methionine-choline-sufficient
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NASH non-alcoholic steatohepatitis
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Figure 1. NOX deficient (p47phox knock out (KO)) mice are resistant to liver fibrosis induced by
bile duct ligation (BDL) or carbon tetrachloride (CCl4)
(A, B) Sirius red staining of liver sections from WT and p47phox KO mice 3 weeks after
BDL or (C, D) after 16 injections (every 3 days) of CCl4. (E, F) mRNA expression of
Collagen α1(I) and αSMA were evaluated by quantitative real-time PCR from RNA
extracted from total liver tissue of WT and p47phox KO mice 3 weeks after BDL (E) or 16
injections of CCl4 (F). Protein expression of αSMA was evaluated by western blot analysis
from livers of wild type or p47phox KO mice after 3 weeks of BDL (E) or 16 injections of
CCl4 (F). *, p<0.05. Original Magnification, ×100 (A–D). Data are representative of three
independent experiments.
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Figure 2. NOX expression and ROS production in different liver cell types
(A) mRNA expression of p47phox was evaluated by quantitative real-time PCR from RNA
extracted from different cell types, including hepatic stellate cells (HSC), Endothelial cells,
Kupffer cells, Hepatocytes and Fibrocytes, isolated from control mice or mice 2 weeks after
bile duct ligation (n=3). *, p<0.05 cells isolated from BDL mice vs normal mice; #, p<0.05
cells isolated from BDL mice vs HSCs isolated from BDL mice; §, p<0.05 cells isolated
from BDL mice vs Kupffer cells isolated from BDL mice. (B–D) Double
immunofluorescence staining for 4-hydroxynonenal (4-HNE) (red fluorescence, upper
panel) and (B) F4/80 (KC), (C) αSMA (HSC) or (D) Pan-cytokeratin (HEP) (all green
fluorescence, middle panel). The liver sections were from (B–D) bile duct-ligated mice.
Arrow head indicates double positive cells. Asterisk indicates bile duct lumens. Original
magnification, ×200 (B–D). Magnification of the inset, ×400 (B–D). Data are representative
of three independent experiments.
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Figure 3. Chimeric mice with NOX-deficient (p47phox KO) recipient cells have decreased
fibrosis compared to mice with NOX-deficient bone marrow (BM)-derived cells
Chimeric mice were generated by injecting BM cells into mice pretreated with clodronate
and lethal irradiation. The following groups were generated: WT BM → WT mice; WT BM
→ p47phox KO mice; p47phox KO BM → WT mice, and p47phox KO BM → p47phox
KO mice. (A) Collagen deposition assessed by Sirius red staining, (B) Quantification of
collagen deposition by computerized imaging analysis and (C) Hydroxyproline content
assessed by absorbance assay, were evaluated in chimeric mice. *, p<0.05 vs WT BM →
WT mice; #, p<0.045 vs p47phox KO BM → WT mice. (D) Immunohistochemistry for
αSMA. (E) Western blot from total liver samples for αSMA. (F) Quantification by qPCR of
mRNA expression for collagen α1(I) and αSMA in all groups of chimeric mice. *, p<0.05 vs
WT BM → WT mice; #, p<0.045 vs p47phox KO BM → WT mice. Original Magnification,
×100 (A, D).
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Figure 4. Chimeric mice with NOX-deficient (p47phox KO) recipient cells have decreased
peroxidation compared to mice with NOX-deficient BM-derived cells
(A) Immunohistochemistry for 4-hydroxynonenal (4-HNE) and (B) Thiobarbituric acid
reactive substances (TBARS) measurement from total liver samples was evaluated in all
groups of chimeric mice (as indicated in Fig. 3) after 3 weeks of BDL. *, p<0.05 vs WT BM
→ p47phox KO mice. (C, D) Double immunofuorescence staining for 4-HNE (red
fluorescence) and αSMA (green fluorescence) in (C) p47phox KO BM → WT mice and (D)
WT BM → p47phox KO mice. Closed and open arrow heads indicate double positive cells
and ROS negative cells, respectively. Asterisk indicates bile duct lumens. v, vessle lumens.
Original Magnification, ×100 (A), ×200 (C, D). Magnification of the inset, ×400 (C, D).
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Figure 5. WT and NOX-deficient (p47phox KO) mice fed with MCD diet for 10 weeks show
comparable levels of steatosis and inflammation
(A) body weight and liver weight/body weight ratio, (B) serum levels of AST and ALT and
(C) mRNA levels of Timp-1, MCP-1 and TNFα in total liver samples were assessed in WT
and KO mice treated with MCS and MCD diet for 10 weeks. *, p<0.05 vs WT MCD. (D)Oil
red O staining (E) and computerized quantification of lipid deposition, and (F) triglyceride
content from total liver tissues were evaluated. Original Magnification, ×100 (D),
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Figure 6. WT and NOX-deficient (p47phox KO) mice fed with MCD diet for 10 weeks show
comparable levels of peroxidation
(A) Immunohistochemistry for 4-hydroxynonenal (4-HNE) expression and (B) TBARS
measurement from total liver tissues and (C) Double Immunofluorescence staining for 4-
HNE (red fluorescence) and Pan-cytokeratin (parenchymal cell) (green fluorescence) was
evaluated in wild type and p47phox KO mice fed for 10 weeks with an MCS or MCD diet.
Asterisk indicates bile duct lumens. v, vessle lumens. Original Magnifications, ×100 (A),
×200 (C). Magnification of the inset, ×400 (C).
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Figure 7. MCD diet for 10 weeks induced fibrosis in WT but not in NOX deficient (p47phox KO)
mice
(A) Sirius red staining of the livers of WT and p47phox KO mice fed control MCS diet or
MCD diet. (B) Quantitative real-time PCR of mRNA expressions for collagen α1(I) and
αSMA in WT or p47phox KO mice after 10 weeks of MCS or MCD diet are shown. *,
p<0.05 vs WT MCD. Original Magnification, ×100 (A).
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Figure 8. Both WT and NOX-deficient (p47phox KO) hepatocytes treated with free fatty acids
(FFAs) show increased lipid deposition and ROS production
Hepatocytes isolated from wild type and p47phox KO mice were cultured on collagen I
coated plastic dishes and incubated for 24 h with palmitic acid (PALM) (200 μM). (A) Lipid
deposition was evaluated by Oil-Red O staining. (B) After 24 h incubation with PALM,
hepatocytes were loaded with DCFDA (8 μM) for 20 minutes. Fluorescent signals were
quantified using a fluorometer at excitation and emission wavelengths of 488 nm and 520
nm, respectively. *, p<0.05 vs WT PALM; # p<0.05 vs KO PALM. Original Magnification,
×200 (A).
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